Ş. Aydınlık Et Al. , "Targeting cancer stem cells by inhibiting WNT pathway combination of Pd II complex and niclosamide," In vitro evaluation of compounds with anticancer potential COST Action CM1407 , 2016
Aydınlık, Ş. Et Al. 2016. Targeting cancer stem cells by inhibiting WNT pathway combination of Pd II complex and niclosamide. In vitro evaluation of compounds with anticancer potential COST Action CM1407 .
Aydınlık, Ş., Erkısa, M., CEVATEMRE, B., ARI, F., YILMAZ, V. T., ULUKAYA, E., ... Aztopal, N.(2016). Targeting cancer stem cells by inhibiting WNT pathway combination of Pd II complex and niclosamide . In vitro evaluation of compounds with anticancer potential COST Action CM1407
Aydınlık, Şeyma Et Al. "Targeting cancer stem cells by inhibiting WNT pathway combination of Pd II complex and niclosamide," In vitro evaluation of compounds with anticancer potential COST Action CM1407, 2016
Aydınlık, Şeyma Et Al. "Targeting cancer stem cells by inhibiting WNT pathway combination of Pd II complex and niclosamide." In vitro evaluation of compounds with anticancer potential COST Action CM1407 , 2016
Aydınlık, Ş. Et Al. (2016) . "Targeting cancer stem cells by inhibiting WNT pathway combination of Pd II complex and niclosamide." In vitro evaluation of compounds with anticancer potential COST Action CM1407 .
@conferencepaper{conferencepaper, author={Şeyma Aydınlık Et Al. }, title={Targeting cancer stem cells by inhibiting WNT pathway combination of Pd II complex and niclosamide}, congress name={In vitro evaluation of compounds with anticancer potential COST Action CM1407}, city={}, country={}, year={2016}}